Ginsenosides, the main active components of ginseng, have been reported to exert
neuroprotective effects in the central nervous system. In this report, the effects of
ginsenoside-Rd and -Rb2, two protopanaxadiols, and ginsenoside-Rg1 and -Re, two protopanaxatriols, on the production of
nitric oxide (NO) and
TNF-alpha (
TNF-alpha) by
lipopolysaccharide (LPS)-activated N9 microglial cells were studied. All
ginsenosides studied potently suppressed
TNF-alpha production in LPS-activated N9 cells. Ginsenoside-Rg1 and -Re, but not ginsenoside-Rb2 and -Rd, inhibited the production of NO in LPS-activated N9 cells.
Ginsenosides inhibited the phosphorylation of c-Jun NH2-terminal
kinase (JNK), c-Jun and
extracellular signal-regulated kinase (ERK), The findings herein show that the inhibition of LPS-induced ERK1/2 and JNK activation may be a contributing factor to the main mechanisms by which
ginsenosides inhibits RAW264.7. To clarify the mechanistic basis for its ability to inhibit
TNF-alpha and NO induction, the effect of
ginsenosides on
transcription factor NF-kappaB protein level was also examined. These activities were associated with the down-regulation of inhibitor kappaB (IkappaB). These findings suggest that the inhibition of LPS-induced NO formation and
TNF-alpha production in microglia by
ginsenosides is due to its inhibition of
NF-kappaB, which may be the mechanistic basis for the anti-inflammatory effects of
ginsenosides. The significant suppressive effects of
ginsenosides on proinflammatory responses of microglia implicate their therapeutic potential in
neurodegenerative diseases accompanied by microglial activation.